Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 3/2014

01-09-2014 | Correspondence

Chronic Idiopathic Non-Cirrhotic Portal Vein Thrombosis Treated with a Mesocaval Shunt Procedure and Anticoagulation

Authors: Hamid Shaaban, Nihar Shah, Ibrahim Sidhom

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2014

Login to get access

Abstract

Portal vein thrombosis (PVT) was first reported in 1868 by Balfour and Stewart and is a medical condition in which the lumen of the portal vein is completely or partially obstructed due to the presence of a thrombus [1]. Inherited (Factor V Leiden and Prothrombin gene mutation G201210A, Protein C, S and Anti thrombin III deficiency) and acquired thrombophilias (Lupus Anticoagulant, myeloproliferative diseases, malignancy, surgery and trauma) account for majority of the cases of PVT.
Literature
1.
Balfour GW, Stewart TG (1869) Case of enlarged spleen complicated with ascites, both depending upon varicose dilatation and thrombosis of the portal vein. Edinb Med J 14:589–598
2.
3.
Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH (2006) Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 12:2115–2119PubMed
4.
Valla DC, Condat B (2000) Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 32:865–871PubMedCrossRef
5.
Sheen CL, Lamparelli H, Milne A, Green I, Ramage JK (2000) Clinical features, diagnosis and outcome of acute portal vein thrombosis. QJM 93(8):531–534PubMedCrossRef
Metadata
Title
Chronic Idiopathic Non-Cirrhotic Portal Vein Thrombosis Treated with a Mesocaval Shunt Procedure and Anticoagulation
Authors
Hamid Shaaban
Nihar Shah
Ibrahim Sidhom
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-013-0237-4

Other articles of this Issue 3/2014

Indian Journal of Hematology and Blood Transfusion 3/2014 Go to the issue

Review Article

Blood Substitutes: Possibilities with Nanotechnology

Original Article

Blood Transfusion Practice in Obstetric and Gynecology: Impact of Educational Programs to Create Awareness for Judicious Use of Blood Components

Short Communication

Pleural Effusion as an Unusual Initial Presentation of Acute Myeloid Leukemia

Review Article

Primary Hepatic Lymphoma: Dilemmas in Diagnostic Approach and Therapeutic Management

Original Article

Platelet Storage Media Change the Expression Characteristics of the Platelet-Derived Microparticles

Case Report

Rare Case of Acquired Haemophilia and Lupus Anticoagulant
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits